Form 4: Intuitive Surgical EVP Myriam Curet Executes Stock Transactions
SEC Form 4 Filing
Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, reports stock transactions including the vesting of Restricted Stock Units (RSUs) and subsequent sale of shares to cover tax obligations.
Summary
- Myriam Curet, an executive at Intuitive Surgical, engaged in several transactions involving the company's stock.
- On February 10, 2025, 838 shares were acquired through the vesting of Restricted Stock Units (RSUs) at a price of $0.00.
- Also on February 10, 2025, 430 shares were disposed of to cover tax obligations at a price of $582.98.
- On February 11, 2025, 408 shares were sold at a price of $589.75.
- Following these transactions, Curet directly owns 353 shares of Intuitive Surgical stock and 1,676 Restricted Stock Units.
- The sale of shares on February 11, 2025, was executed under a pre-arranged trading plan complying with SEC Rule 10b5-1, set to expire on August 13, 2025.
Sentiment
Score: 5
Explanation: The document reflects routine stock transactions by an executive, which are neither overtly positive nor negative. The use of a pre-arranged trading plan suggests a neutral sentiment.
Future Outlook
The executive's future stock transactions may continue under the existing 10b5-1 trading plan, which expires on August 13, 2025.
Industry Context
Executive stock transactions are a routine part of corporate governance and are closely monitored by investors for insights into management's perspective on the company's performance and future prospects. The use of 10b5-1 trading plans is a common practice to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation packages in the medical device industry often include stock options and restricted stock units to align management's interests with those of shareholders.
- Companies like Stryker, Medtronic, and Johnson & Johnson also utilize similar equity-based compensation strategies for their executives.
- The vesting schedules and trading plans are generally structured to comply with SEC regulations and promote long-term value creation.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are part of a pre-arranged trading plan and involve a relatively small number of shares.
- Shareholders may view these transactions as a routine part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| February 10, 2023 | Commencement date for RSU vesting, with 25% vesting annually over four years. |
| February 10, 2025 | RSU vesting date; 838 shares acquired and 430 shares disposed of for tax obligations. |
| February 11, 2025 | Sale of 408 shares under a 10b5-1 trading plan. |
| August 13, 2025 | Expiration date of the 10b5-1 trading plan. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.